The role of genetic variants in the prediction of hearing loss due to cisplatin chemoradiotherapy
This study underscores the importance of the rs2289669 SNP in CIHL and demonstrates the potential of combining genetic and clinical data for enhanced predictive models in personalized treatment strategies.
Authors
- Andrew Hope (ORCID: https://orcid.org/0000-0001-6793-2863)
- Katarzyna Jóźwiak (ORCID: https://orcid.org/0000-0002-9614-6586)
- Sabrina Chiodo (ORCID: https://orcid.org/0000-0001-6722-1017)
- Dangxiao Cheng (ORCID: https://orcid.org/0000-0001-6915-0742)
- Michael Hauptmann (ORCID: https://orcid.org/0000-0001-8539-0148)
- Katrina Hueniken (ORCID: https://orcid.org/0000-0003-1376-8046)
- Charlotte L. Zuur (ORCID: https://orcid.org/0000-0002-1777-012X)
- Charlotte W. Duinkerken (ORCID: https://orcid.org/0000-0001-9194-6560)
- Geoffrey Liu (ORCID: https://orcid.org/0000-0002-2603-7296)
Institutions
- University Health Network (CA)
- University of Toronto (CA)
- Leiden University Medical Center (NL)
- Princess Margaret Cancer Centre (CA)
- The Netherlands Cancer Institute (NL)
- Public Health Ontario (CA)
- Medizinische Hochschule Brandenburg Theodor Fontane (DE)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1002/cam4.7465
- Citations
- 2
- Primary Topic
- Brain Metastases and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.84